Z. Esmaeeli, M.R. Khodabakhshi, Z. Mirjafary et al.
Journal of Molecular Structure 1246 (2021) 131206
2
.4. General procedure for the synthesis of 4a-d
114.4 (CH), 120.9 (C), 122.3 (C), 122.8 (CH), 123.8 (C), 127.0 (CH),
128.2 (CH), 128.3 (CH), 128.7 (2CH), 128.8 (CH), 128.9 (2CH),
A mixture of diazepam 3 (1 mmol) and O-propargyl salicylalde-
129.3 (CH), 130.3 (C), 130.8 (CH), 130.9 (2CH), 131.3 (CH), 132.0
(2CH), 136.7 (C), 138.1 (C), 139.4 (C), 141.1 (C), 141.4 (C), 163.7
(C), 167.2 (C=O), 170.7 (C=N). Anal. Calcd for C33H25ClN O : C,
hyde 2a-c (1 mmol) in t-BuOH (5 mL) was heated and treated
slowly with KOt-Bu/t-BuOH (1 mmol/ 5 mL). The reaction mixture
was refluxed for 3–6 h. The reaction was monitored by TLC. The
solvent was then removed under reduced pressure, and the mix-
ture was purified by silica gel column chromatography (n-hexane-
EtOAc, 3/1) to give the desired pure products 4a-d.
6
4
65.51; H, 4.16; N, 13.89, Found: C, 65.57; H, 4.20; N, 13.80. 3-
(2-((1-benzyl-1H-1, 2, 3-triazol-4-yl) methoxy)-5-bromobenzylidene)-
7-chloro-1-methyl-5-phenyl-1, 3-dihydro-2H-benzo[e] [1, 4] diazepin-
2-one 6d: yellow powder, m.p.: 140-144°C; FT-IR (KBr): 3441, 3129,
−
1
1
3
067, 2922, 2855, 1661, 1609, 741, 694 cm
;
HNMR: δ = 3.36
(3H, s, Me), 5.12 (2H, d, 3J = 4.5, NCH2), 5.45 (2H, s, OCH2), 6.71
2
.5. General procedure for the synthesis of 1,2,3-triazole-based
diazepam 6a-j
(1H, s, CH), 7.19-7.22 (6H, m, 6CH), 7.27-7.31 (3H, m, 3CH), 7.38-
7
.47 (4H, m, 4CH), 7.53 (1H, s, CH), 7.76-7.80 (2H, m, 2CH), 7.92
(H, d, 3J = 4.5, CH); CNMR: δ = 35.7 (Me), 51.3 (NCH2), 61.6
(OCH2), 106.9 (C), 112.9 (CH), 114.2 (C), 122.3 (C), 122.4 (C), 122.9
(CH), 123.9 (CH), 124.0 (CH), 125.2 (2CH), 126.5 (2CH), 128.1 (2CH),
128.6 (2CH), 128.7 (CH), 129.1 (C), 129.9 (CH), 131.3 (CH), 131.4
(CH), 131.6 (CH), 133.3 (C), 134.1 (C), 137.0 (C), 140.8 (C), 149.5
13
NaN3 is toxic and potentially explosive material and therefore
the reaction should be carried out only by a trained professional
in an efficient chemical hood [35].
In a tube equipped with a magnetic stirring bar, 4a-d (1 mmol)
and benzyl bromide 5 (1 mmol) were added in water (15 mL).
Then sodium azide (1 mmol), Cu(OAc)2 (0.2 mmol), sodium ascor-
bate (0.2 mmol) were added to the reaction mixture, which was
stirred for 24 h at room temperature and subsequently extracted
with ethyl acetate (3 × 15 mL). The combined organic extracts
were dried over anhydrous Na SO , and the solvent was evapo-
+
(C), 150.3 (C), 161.3 (C=O), 166.4 (C=N); MS (ESI): 640 [M+H] ;
Anal. Calcd for C33H25BrClN5O2: C, 62.03; H, 3.94; N, 10.96, Found:
C, 62.00; H, 3.98; N, 10.93. 3-(5-bromo-2-((1-(4-bromobenzyl)-1H-1,
2, 3-triazol-4-yl) methoxy) benzylidene)-7-chloro-1-methyl-5-phenyl-
1, 3-dihydro-2H-benzo[e] [1, 4] diazepin-2-one 6e: yellow powder,
m.p.; 139-143°C; FT-IR (KBr): 3437, 3129, 3069, 2922, 2864, 1659,
2
4
rated. Finally, the crude product was purified by silica gel column
chromatography ((n-hexane-EtOAc, 4/1) to afford the desired pure
products 6a-j as yellow powders.
−1
1
1605, 779, 691 cm
3
;
HNMR: δ = 3.36 (3H, s, Me), 5.13 (2H, dd,
J = 24.0, 7.0, NCH2), 5.40 (2H, s, OCH2), 6.72 (1H, s, CH), 6.80 (2H,
3
dd, J = 12.5, 6.0, CH), 7.06-7.11 (2H, m, 2CH), 7.19-7.22 (2H, m,
2CH), 7.25 (1H, s, CH), 7.25 (1H, d, 3J= 2.0, CH), 7.38-7.49 (4H, m,
2
.6. Spectral data of 1,2,3-triazole-based diazepam 6a-j
-(2-((1-benzyl-1H-1, 2, 3-triazol-4-yl) methoxy) benzylidene)-7-
3
4
CH), 7.57 (1H, s, CH), 7.76-7.80 (2H, m, 2CH), 7.89 (1H, d, J = 5.0,
CH); 13CNMR: δ = 35.7 (Me), 53.5 (NCH2), 63.2 (OCH2), 113.1 (CH),
113.6 (C), 114.3 (CH), 122.7 (CH), 122.9 (CH), 123.0 (C), 126.6 (C),
128.7 (2CH), 129.4 (C), 129.5 (CH), 129.8 (CH), 129.9 (2CH), 131.1
(C), 131.4 (CH), 131.5 (2CH), 131.6 (CH), 132.3 (2CH), 133.4 (C),
134.1 (CH), 137.2 (C), 140.8 (C), 141.7 (C), 144.3 (C), 155.2 (C), 164.4
(C=O), 170.8 (C=N); Anal. Calcd for C33H24Br2ClN5O2: C, 55.22;
H, 3.37; N, 9.76, Found: C, 55.13; H, 3.42; N, 9.81. 3-(5-bromo-2-
((1-(4-nitrobenzyl)-1H-1, 2, 3-triazol-4-yl) methoxy) benzylidene)-7-
chloro-1-methyl-5-phenyl-1, 3-dihydro-2H-benzo[e] [1, 4] diazepin-2-
one 6f: yellow powder, m.p.: 147-150°C; FT-IR (KBr): 3437, 3138,
3
chloro-1-methyl-5-phenyl-1, 3-dihydro-2H-benzo[e] [1, 4] diazepin-2-
one 6a: yellow powder; m.p.: 136-138°C; FT-IR (KBr): 3441, 3165,
−
1
1
3
024, 2920, 2850, 1660, 1601, 754, 698 cm
;
HNMR: δ = 3.53
(
3H, s, Me), 5.34 (2H, dd, 3J =12.0, 8.0, NCH ), 5.63 (2H, s, OCH ),
2
2
7
.02 (1H, s, CH), 7.31-7.40 (5H, m, 5CH), 7.42 (1H, d, 3J =2.5,
CH), 7.44-7.61 (9H, m, 9CH), 7.77 (1H, s, CH), 7.94-7.96 (2H, m,
2
CH); 13CNMR: δ = 35.6 (Me), 53.3 (NCH ), 62.0 (OCH ), 112.6
2
2
(
(
CH), 113.0 (CH), 121.3 (C), 123.8 (CH), 124.6 (C), 125.3 (CH), 128.4
CH), 128.5 (CH), 128.6 (2CH), 128.9 (CH), 129.2 (2CH), 129.3 (2CH),
−
1
1
129.8 (CH), 129.9 (2CH), 131.0 (CH), 131.1 (C), 131.9 (CH), 132.1
3075, 2924, 2859, 1650, 1607, 754, 694 cm
.
HNMR: δ = 3.41
(3H, s, Me), 5.18-5.27 (2H, dd, 3J = 19.0, 12.0, NCH2), 5.63 (2H, s,
OCH2), 6.78 (1H, s, CH), 6.87-6.89 (1H, d, 3J = 8.5, CH), 7.31 (2H,
s, 2CH), 7.40-7.42 (2H, m, 2CH), 7.48-7.55 (4H, m, 4CH), 7.76 (1H,
s, CH), 7.82-7.89 (4H, m, 4CH), 8.21-8.22 (2H, m, 2CH); 13CNMR:
δ = 35.2 (Me), 52.8 (NCH2), 63.0 (OCH2), 112.8 (CH), 114.0 (C),
114.1 (CH), 122.3 (CH), 122.7 (CH), 122.9 (C), 123.9 (C), 125.7 (2CH),
126.1 (C), 126.3 (CH), 128.3 (CH), 129.1 (2CH), 129.4 (C), 130.0
(CH), 130.9 (2CH), 131.1 (CH), 131.2 (2CH), 133.7 (C), 134.8 (C),
137.9 (C), 141.2 (C), 142.9 (C), 146.3 (C), 159.9 (C), 166.8 (C=O),
170.3 (C=N); Anal. Calcd for C33H24BrClN6O4: C, 57.95; H, 3.54; N,
12.29, Found: C, 58.01; H, 3.59; N, 12.27. 3-(2-((1-benzyl-1H-1, 2,
3-triazol-4-yl) methoxy)-5-methoxybenzylidene)-7-chloro-1-methyl-5-
phenyl-1, 3-dihydro-2H-benzo[e] [1, 4] diazepin-2-one 6g: yellow
powder, m.p.: 137-139°C; FT- IR (KBr): 3447, 3136, 3069, 2926,
(
CH), 136.4 (C), 137.2 (C), 140.6 (C), 142.1 (C), 142.2 (C), 156.3
(
C), 164.6 (C=O), 170.4 (C=N). Anal. Calcd. for C33H26ClN O : C,
5
2
7
0.77; H, 4.68; N, 12.51, Found: C, 70.65; H, 4.87; N, 12.41. 3-(2-
((1-(4-bromobenzyl)-1H-1, 2, 3-triazol-4-yl) methoxy) benzylidene)-7-
chloro-1-methyl-5-phenyl-1, 3-dihydro-2H-benzo[e] [1, 4] diazepin-2-
one 6b: yellow powder, m.p.: 137-139°C; FT-IR (KBr): 3443, 3138,
−
1
1
3
065, 2924, 2859, 1661, 1599, 752, 696 cm
;
HNMR: δ = 3.35
(
3H, s, Me), 5.17 (2H, dd, 3J = 24, 6.5, NCH ), 5.41 (2H, s, OCH ),
2
2
6
.84 (1H, s, CH), 6.91-6.94 (2H, m, 2CH), 7.07-7.19 (5H, m, 5CH),
7
.37-7.47 (6H, m, 6CH), 7.56 (1H, dd 3J = 3.5, 13, CH), 7.62 (1H, s,
CH), 7.75-7.79 (2H, m, 2CH); 13CNMR: δ = 35.6 (Me), 53.3 (NCH ),
2
6
3.2 (OCH2), 112.7 (CH), 114.6 (CH), 121.2 (C), 122.7 (C), 122.8
(
CH), 122.9 (C), 124.6 (CH), 128.6 (CH), 129.1 (CH), 129.2 (2CH),
29.3 (CH), 129.7 (2CH), 131.2 (CH), 131.4 (C), 132.3 (CH), 133.6
1
−1
1
(
(
2CH), 137.2 (CH), 139.9 (2CH), 141.9 (C), 142.5 (C), 144.9 (C), 151.4
2857, 1661, 1605, 754, 702 cm
.
HNMR: δ = 3.36 (3H, s, Me),
3.77 (3H, s, OMe), 5.13 (2H, dd, 3J = 25.0, 58.0, NCH2), 5.46 (2H,
s, OCH2), 6.77-6.80 (2H, m, 2CH), 6.94-7.09 (2H, m, 2CH), 7.16-7.23
(6H, m, 6CH), 7.25-7.27 (1H, m, 1 CH), 7.37-7.48 (4H, m, 4CH), 7.74-
7.78 (2H, m, 2CH), 7.97 (1H, s, CH); 13CNMR: δ = 33.1 (Me), 55.8
(OMe), 57.6 (NCH2), 67.2 (OCH2), 108.4 (C), 111.5 (CH), 115.2 (CH),
118.3 (CH), 122.8 (C), 123.8 (C), 123.9 (CH), 125.3 (CH), 125.4 (CH),
126.1 (2CH), 128.2 (2CH), 128.4 (2CH), 128.6 (2CH), 128.9 (CH),
129.2 (C), 129.8 (CH), 130.4 (CH), 131.4 (2CH), 132.2 (C), 132.9 (C),
137.2 (C), 140.5 (C), 144.9 (C), 152.6 (C=O), 158.8 (C=N); MS (ESI):
C), 151.5 (C), 156.3 (C), 163.9 (C=O), 171.1 (C=N). Anal. Calcd
for C
H BrClN O : C, 62.03; H, 3.94; N, 10.96, Found: C, 62.14;
25 5 2
33
H, 3.86; N, 10.90. 7-chloro-1-methyl-3-(2-((1-(4-nitrobenzyl)-1H-1,
, 3-triazol-4 yl) methoxy) benzylidene)-5-phenyl-1, 3-dihydro-2H-
2
benzo[e] [1, 4] diazepin-2-one 6c: yellow powder, m.p.: 142.145°C;
FT-IR (KBr): 3426, 3138, 3069, 2928, 2862, 1661, 1601, 746, 700
cm 1. 1HNMR: δ = 3.41 (3H, s, Me), 5.26 (2H, dd, J = 17.5, 12,
−
3
NCH ), 5.64 (2H, s, OCH ), 6.89 (1H, s, CH), 6.99- 7.01 (2H, m,
2
2
2
CH), 7.27-7.32 (1H, m, CH), 7.39-7.49 (6H, m, 6CH), 7.54- 7.57
+
(
1H, m, CH), 7.68- 7.71 (4H, m, 4CH), 7.81-7.83 (3H, m, 3CH);
590 [M+H] ; Anal. Calcd for C34H28ClN5O3: C, 69.21; H, 4.78; N,
1
3
CNMR: δ = 35.1 (Me), 52.7 (NCH ), 67.7 (OCH ), 112.6 (CH),
11.87, Found: C, 69.11; H, 4.73; N, 11.91. 3-(2-((1-(4-bromobenzyl)-
2
2
3